Credit Suisse’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,024
| Closed | -$379K | – | 2980 |
|
|
2023
Q4 | $379K | Sell |
7,024
-6,010
| -46% | -$294K | ﹤0.01% | 2849 |
|
|
2023
Q3 | $632K | Buy |
13,034
+5,747
| +79% | +$306K | ﹤0.01% | 2559 |
|
|
2023
Q2 | $411K | Sell |
7,287
-13,576
| -65% | -$748K | ﹤0.01% | 2881 |
|
|
2023
Q1 | $1.13M | Sell |
20,863
-74,071
| -78% | -$3.94M | ﹤0.01% | 2251 |
|
|
2022
Q4 | $4.99M | Sell |
94,934
-14,048
| -13% | -$713K | 0.01% | 1303 |
|
|
2022
Q3 | $5.14M | Buy |
108,982
+50,036
| +85% | +$2.6M | 0.01% | 1237 |
|
|
2022
Q2 | $2.97M | Buy |
58,946
+21,045
| +56% | +$1.15M | ﹤0.01% | 1641 |
|
|
2022
Q1 | $2.31M | Sell |
37,901
-19,120
| -34% | -$1.14M | ﹤0.01% | 1983 |
|
|
2021
Q4 | $3.75M | Sell |
57,021
-30,399
| -35% | -$1.95M | ﹤0.01% | 2263 |
|
|
2021
Q3 | $5.49M | Buy |
87,420
+37,098
| +74% | +$2.37M | ﹤0.01% | 1979 |
|
|
2021
Q2 | $3.03M | Buy |
+50,322
| New | +$2.91M | ﹤0.01% | 2514 |
|
|
2021
Q1 | – | Sell |
-6,078
| Closed | -$337K | – | 4423 |
|
|
2020
Q4 | $332K | Sell |
6,078
-4,836
| -44% | -$253K | ﹤0.01% | 3944 |
|
|
2020
Q3 | $545K | Buy |
10,914
+1,872
| +21% | +$90.7K | ﹤0.01% | 3338 |
|
|
2020
Q2 | $399K | Sell |
9,042
-8,238
| -48% | -$352K | ﹤0.01% | 3443 |
|
|
2020
Q1 | $649K | Buy |
+17,280
| New | +$728K | ﹤0.01% | 2967 |
|
|
2017
Q4 | – | Sell |
-229,092
| Closed | -$6.38M | – | 4093 |
|
|
2017
Q3 | $6.38M | Sell |
229,092
-13,626
| -6% | -$377K | 0.01% | 1579 |
|
|
2017
Q2 | $6.74M | Sell |
242,718
-141,648
| -37% | -$3.75M | 0.01% | 1433 |
|
|
2017
Q1 | $9.7M | Buy |
384,366
+111,810
| +41% | +$2.71M | 0.01% | 1245 |
|
|
2016
Q4 | $6.05M | Buy |
272,556
+137,340
| +102% | +$3.12M | 0.01% | 1519 |
|
|
2016
Q3 | $3.28M | Buy |
+135,216
| New | +$3.22M | ﹤0.01% | 1997 |
|
|
2016
Q2 | – | Sell |
-226,626
| Closed | -$4.63M | – | 4267 |
|
|
2016
Q1 | $4.63M | Buy |
226,626
+21,894
| +11% | +$425K | 0.01% | 1599 |
|
|
2015
Q4 | $4.18M | Sell |
204,732
-1,296,936
| -86% | -$26M | ﹤0.01% | 1725 |
|
|
2015
Q3 | $27.9M | Buy |
1,501,668
+349,128
| +30% | +$7.02M | 0.03% | 580 |
|
|
2015
Q2 | $23M | Buy |
1,152,540
+818,154
| +245% | +$16.4M | 0.02% | 768 |
|
|
2015
Q1 | $6.7M | Buy |
334,386
+243,624
| +268% | +$4.76M | 0.01% | 1445 |
|
|
2014
Q4 | $1.71M | Sell |
90,762
-301,764
| -77% | -$5.45M | ﹤0.01% | 2676 |
|
|
2014
Q3 | $6.5M | Buy |
392,526
+116,040
| +42% | +$1.97M | 0.01% | 1558 |
|
|
2014
Q2 | $4.7M | Buy |
+276,486
| New | +$4.52M | ﹤0.01% | 2016 |
|
|
2014
Q1 | – | Sell |
-365,772
| Closed | -$5.66M | – | 4761 |
|
|
2013
Q4 | $5.66M | Buy |
365,772
+307,380
| +526% | +$4.58M | 0.01% | 1734 |
|
|
2013
Q3 | $824K | Buy |
58,392
+13,662
| +31% | +$188K | ﹤0.01% | 3116 |
|
|
2013
Q2 | $585K | Buy |
+44,730
| New | +$580K | ﹤0.01% | 3191 |
|
Other funds holding IHI
Credit Suisse's IHI Position: Q1 2024 in Review
Credit Suisse sold out of iShares US Medical Devices ETF (IHI) in Q1 2024, closing a stake of 7,024 shares — an estimated $379K sold.
Credit Suisse first reported a position in IHI in Q2 2013 and held it in 31 quarters. The position peaked at $27.9M in Q3 2015. 584 funds tracked by Wall St. Rank hold IHI as of Q1 2024.
- Credit Suisse reported no remaining iShares US Medical Devices ETF position as of Q1 2024 after selling out during the quarter.
- Credit Suisse sold 7,024 iShares US Medical Devices ETF shares in Q1 2024, an estimated $379K.
- Credit Suisse first reported a position in iShares US Medical Devices ETF in Q2 2013 and held it in 31 quarters.
- Credit Suisse's iShares US Medical Devices ETF position peaked at $27.9M in Q3 2015.
- 584 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.